Searching journal content for articles similar to Ji et al. 34 (4): 633.

Displaying results 1-10 of 14
For checked items
  1. ...of this model to intratumor heterogeneity. As a byproduct of this confounding effect, we evaluate whether the inverse relationship between mutant allele enrichment in RNA and tumor purity could be leveraged to complement DNA-based somatic mutation detection in low purity samples. Indeed, our de novo somatic...
  2. ...Research 27:1704–1714 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/17; www..org www..org protein-coding regions (“exons”) of the , an approach called whole-exome sequencing (WES) (Koboldt et al. 2013). Indeed, sequencing of the whole (WGS) offers several advantages compared to WES...
  3. ...number alterations (CNAs), which occur in more than 90% of solid tumors (Hieronymus et al. 2018; Hoadley et al. 2018; Steele et al. 2022; Martínez-Jiménez et al. 2023). In addition to traditional genomic mutation features, -wide cfDNA sequencing also enables the detection of so-called fragmentomics...
  4. ...Somatic retrotransposition in human cancer revealed by whole-genome and exome sequencing Elena Helman 1 , 2 , Michael S. Lawrence 2 , Chip Stewart 2 , Carrie Sougnez 2 , Gad Getz 2 , 3 and Matthew Meyerson 1 , 2 , 4 , 5 , 6...
  5. ...pathogenic repeats is unlikely to work with whole-exome sequence data because (1) many repeats of interest are not exonic; and (2) size estimates for large repeats require assumptions about the average number of reads per base. Additionally, some important repeats, like the repeat in FMR1 gene that causes...
  6. ...(SNVs) and small indels (i.e., SNVs exclusively mean base substitutions). We used the whole-exome sequences (WXSs) data of 3,349,768 somatic mutations in 32 cancer types in 9482 patient samples in The Cancer Genome Atlas (TCGA; see Methods) (for details, see Supplemental Table S1). The coverage exceeded...
  7. ...architecture of this residual population is critical for the development of successful therapies. We used whole-genome sequencing and whole-exome sequencing of multiple sectors from primary and paired recurrent GBM tumors to reconstruct the genomic profile of residual, therapy resistant tumor initiating cells...
  8. ...Next generation sequencing has enabled systematic discovery of mutational spectra in cancer samples. Here, we used whole genome sequencing to characterize somatic mutations and structural variation in a primary acral melanoma and its lymph node metastasis. Our data show that the somatic mutational...
  9. ..., simulating clonal populations from whole-genome sequences taken from genomically heterogeneous ovarian tumor sites collected from the same patient. In addition, we show in 23 whole genomes of breast tumors that the inference of CNA and LOH using TITAN critically informs population structure and the nature...
  10. ...behavior. Whole-genome and -exome sequencing has contributed to the characterization of the mutational spectrum of the disease, but the underlying transcriptional profile is still poorly understood. We have performed deep RNA sequencing in different subpopulations of normal B-lymphocytes and CLL cells from...
For checked items

Preprint Server